Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.
Bevacizumab treatment can result in tumor shrinkage of progressive vestibular schwannomas in some neurofibromatosis 2 (NF2) patients but its effect on meningiomas has not been defined. To determine the clinical activity of bevacizumab against NF2-related meningiomas, we measured changes in volume of...
Saved in:
Main Authors: | Fabio P Nunes, Vanessa L Merker, Dominique Jennings, Paul A Caruso, Emmanuelle di Tomaso, Alona Muzikansky, Fred G Barker, Anat Stemmer-Rachamimov, Scott R Plotkin |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/f1f7da0af9c04824ac2ec64c9d11a7a4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genomic landscape of high-grade meningiomas
by: Wenya Linda Bi, et al.
Published: (2017) -
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
by: Long-Sheng Chang, et al.
Published: (2021) -
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
by: Sameer Agnihotri, et al.
Published: (2017) -
Isolated Intraconal Meningioma
by: Mohammad Taher Rajabi, et al.
Published: (2021) -
Intraosseous meningioma mimicking osteosarcoma
by: Ruben Delgado, et al.
Published: (2021)